OKUR
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
OKUR
52 hedge funds and large institutions have $169M invested in OnKure Therapeutics, Inc. Class A Common Stock in 2023 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+17
Holders Change %
+48.57%
% of All Funds
0.82%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
20
Increased
19
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
OCA
Octagon Capital Advisors
New York
|
+$12.8M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$11.5M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$6.31M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$6.15M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.2M |
Top Sellers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$656K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$194K |
| 3 |
Millennium Management
New York
|
-$143K |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$118K |
| 5 |
Jane Street
New York
|
-$118K |
